# Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to Peroxidation

> **NCT00466401** · PHASE4 · COMPLETED · sponsor: **Ziv Hospital** · enrollment: 20 (—)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** Ezetimibe

## Key facts

- **NCT ID:** NCT00466401
- **Lead sponsor:** Ziv Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 20 (—)
- **Last updated:** 2013-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00466401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00466401, "Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to Peroxidation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00466401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*